September 2026 in “Journal of Aesthetic Medicine” This review discusses the various determinants of hair quality in healthy individuals and reports no new clinical results; the authors emphasize the need for independent trials with standardized outcomes.
August 2026 in “Journal of the American Academy of Dermatology” This abstract does not report results but indicates that the supplementary material includes comprehensive methodology, additional results, statistical analyses, discussion, and limitations of the Alopecia Areata Relapse Study Group's findings as presented in the main manuscript.
April 2026 in “Asian Journal of Research in Pharmaceutical Sciences” This review highlights the promising potential of Semecarpus anacardium Linn. in promoting hair growth due to its antioxidant and anti-inflammatory properties but emphasizes the need for further human clinical trials and safe formulation practices due to its associated toxicity in raw form.
January 2026 in “Pharmaceutical Medicine” December 2025 in “International Journal of Molecular Sciences” In this study, orally administered Centella asiatica extract, standardized for asiaticoside content, significantly improved skin barrier function, elasticity, and reduced signs of UVB-induced photoaging in hairless mice, highlighting its potential as a nutricosmetic for skin health.
In this study, perilla seed extract obtained through supercritical fluid extraction was found to promote hair follicle cell proliferation and downregulate key genes linked to androgenetic alopecia, showing potential as a natural treatment for hair loss in vitro.
May 2025 in “Frontiers in Bioinformatics” This study used computational methods to identify six molecules, with jamogenin being particularly promising, that effectively bind to and inhibit the enzyme linked to male pattern hair loss, suggesting these compounds could be explored further for hair growth potential.
February 2025 in “BioNanoScience” January 2025 in “Anais Brasileiros de Dermatologia” This review examines male androgenetic alopecia and reports no new clinical results, offering insights to aid dermatologists in making informed therapeutic decisions.
December 2024 in “Animals” In this study, Tithonia diversifolia extract was found to improve certain digestive parameters in crossbred sheep but did not enhance growth performance, as the improvements in digestion did not translate into increased body weight or feed conversion.
November 2024 in “International Journal of Applied Pharmaceutics” This study found that a fenugreek seed extract nanoformulation significantly improved hair growth and length in Wistar rats with alopecia, outperforming conventional gels and oils, suggesting enhanced skin penetration and reduced side effects.
This critical review highlights the anti-carcinogenic properties of luteolin, a plant flavonoid, and examines how encapsulating luteolin in nanoformulations may overcome its bioavailability challenges, potentially enhancing its effectiveness as a safer cancer treatment according to this source.
May 2024 in “Molecules/Molecules online/Molecules annual” This narrative review reports that well-selected plant extracts and their active compounds may improve hair health by promoting hair growth and preventing hair loss, potentially aiding in developing targeted therapies for alopecia.
April 2024 in “Clinical dermatology review (Print)” In this descriptive hospital-based study, researchers found that telogen effluvium was the most common cause of hair loss among women aged 20 to 40, with most cases occurring over 6 weeks to 6 months without an associated illness.
This study observed that women using combined oral contraceptives experienced more nausea, vomiting, and hair loss, while those on Depo-Provera were more likely to gain weight.
July 2023 in “International Journal of Molecular Sciences” In this study, Trapa bispinosa Roxb. pericarp extract demonstrated inhibitory effects on 5α-reductase activity both in vitro using LNCaP cells and in vivo in a mouse model of benign prostatic hyperplasia, suggesting its potential role in managing the condition.
July 2023 in “International Journal of Endocrinology” In this study, researchers observed that Centratherum anthelminticum seed extract effectively reduced cholesterol, triglycerides, insulin resistance, and inflammatory markers, while normalizing hormone levels and oxidative stress markers in rodents with PCOS, suggesting potential benefits for managing the condition.
May 2023 in “Pharmaceuticals” In this in silico study, researchers analyzed nonsynonymous SNPs in the LIPH gene linked to hypotrichosis and identified three potentially harmful variants (W108R, C246S, and H248N) out of 215 total, using sequence- and architecture-based bioinformatics techniques to differentiate between harmful and benign SNPs.
May 2023 in “IntechOpen eBooks” This review outlines the role of testosterone in male sexual development and its therapeutic use for male hypogonadism, covering its biosynthesis, secretion, metabolism, and various biological actions, but does not report specific study results.
May 2023 in “Asian journal of research in pharmaceutical sciences” This study concluded that topical ketoconazole is effective and safe for treating superficial fungal infections and has potential for new dermatologic uses despite concerns over oral administration's adverse effects.
April 2023 in “Clinical Chemistry and Laboratory Medicine” The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.
October 2022 in “Research, Society and Development” This review highlights that while vitamin and mineral supplementation shows limited impact on hair loss treatment, deficiencies in iron, zinc, and vitamin D are common among patients with telogen effluvium.
July 2022 in “Journal of Dermatology and Dermatologic Surgery” This study found that Vitamin B12 deficiency was more common in patients with chronic telogen effluvium than in healthy controls.
June 2022 in “International Journal of Advanced Research in Science, Communication and Technology” This article discusses the composition and benefits of multivitamin gummies, emphasizing their palatability and potential health effects, but reports no new clinical findings.
June 2022 in “International Journal of Advanced Research in Science, Communication and Technology” This study evaluated a polyherbal hair oil formulation that included hibiscus flower and other plant extracts, suggesting it may increase hair growth, reduce hair loss, and provide dandruff protection.
June 2022 in “International Journal of Advanced Research in Science, Communication and Technology” This study explored the development of a herbal shampoo and reported its promising qualities for promoting hair growth and strength, indicating potential for further optimization as a cosmetic product.
June 2022 in “International Journal of Advanced Research in Science, Communication and Technology” This study suggests that a polyherbal hair oil formulation, using traditional herbs like hibiscus and amla, may benefit hair growth, darken white hair, protect against dandruff, and result in shiny hair.
December 2021 in “Asian journal of pharmaceutical and clinical research” In this study, researchers formulated a polyherbal hair oil using ingredients like coconut and castor oils, and reported that it boosts hair growth, reduces hair fall and dandruff, and adds shine, with minimal adverse effects compared to market formulations.
November 2021 in “International Journal of Research in Dermatology” This study found that lower hemoglobin and serum ferritin levels were significantly associated with male pattern hair loss in patients diagnosed with non-cicatricial alopecia.
September 2021 in “Journal of the Egyptian Women's Dermatologic Society (Print)” This study found no significant difference in serum ferritin, zinc, and 25-hydroxy vitamin D levels between women with chronic telogen effluvium and healthy controls, although suboptimal levels were common in both groups.